Understanding Thyroid Eye Disease and Treatment

Recorded On: 10/02/2023


Thyroid eye disease (TED) is a serious, progressive autoimmune disease with a limited window for pharmacologic treatment during the active disease. During this window, the disease may respond to pharmacologic intervention. During this webinar, we will discuss the progression of thyroid eye disease, as well as the symptoms, causes, management, and treatment modalities. 

Learning Outcome: At the conclusion of this webinar, learners will be able to:
1. Describe the causes of TED as well as the symptomatology and the progression of the disease.
2. Discuss management and treatment options available for patients with this condition.

Dr. Alon Kahana, MD, PhD

Dr. Alon Kahana, MD, PhD, is an oculoplastic and orbital surgeon in Michigan, and founder of Kahana Oculoplastic and Orbital Surgery PLLC. Dr. Kahana serves as a professor of ophthalmology and vice chair for academic affairs at Oakland University William Beaumont School of Medicine. Following graduation from Brandeis University, he earned an MD and a PhD in molecular genetics and cell biology at The University of Chicago Pritzker School of Medicine. This education was followed by a residency in ophthalmology and a fellowship in oculofacial plastic and reconstructive surgery at the University of Wisconsin, Madison. Dr. Kahana served on the faculty of the University of Michigan Kellogg Eye Center, rising to the rank of associate professor with tenure. He left the University of Michigan in 2020 to start his own practice. Dr. Kahana’s research interests include tissue repair and regeneration, thyroid eye disease, cancer stem cells, and surgical outcomes. He has received numerous grants and awards, and serves as the president of the North American Society of Academic Orbital Surgeons.

CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

Contact Hours: This session has been approved for 1 contact hour

Expiration date for receipt of contact hours: October 2, 2026

To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.


Understanding Thyroid Eye Disease and Treatment
Live event: 10/02/2023 at 4:00 PM (EDT) You must register to access.
Webinar Evaluation
Printable Certificate You must register to access.